Cargando…
Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines
Neuroblastoma is the most common pediatric cancer, arising from the neural crest cells of the sympathetic nervous system. Its most aggressive subtype, characterized by the amplification of the MYCN oncogene, has a dismal prognosis and no effective treatment is available. Understanding the alteration...
Autores principales: | Dassi, Erik, Greco, Valentina, Sidarovich, Viktoryia, Zuccotti, Paola, Arseni, Natalia, Scaruffi, Paola, Tonini, Gian Paolo, Quattrone, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664780/ https://www.ncbi.nlm.nih.gov/pubmed/26697401 http://dx.doi.org/10.1016/j.gdata.2015.11.012 |
Ejemplares similares
-
Translational compensation of genomic instability in neuroblastoma
por: Dassi, Erik, et al.
Publicado: (2015) -
A Cell-Based High-Throughput Screen Addressing 3′UTR-Dependent Regulation of the MYCN Gene
por: Sidarovich, Viktoryia, et al.
Publicado: (2014) -
MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019) -
The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
por: Misiak, Danny, et al.
Publicado: (2021) -
MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
por: Floros, Konstantinos V., et al.
Publicado: (2022)